GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Cyclically Adjusted PB Ratio

Thelma Therapeutics (XKRX:015540) Cyclically Adjusted PB Ratio : 1.83 (As of Jun. 07, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-06-07), Thelma Therapeutics's current share price is ₩6410.00. Thelma Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 was ₩3,496.56. Thelma Therapeutics's Cyclically Adjusted PB Ratio for today is 1.83.

The historical rank and industry rank for Thelma Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:015540's Cyclically Adjusted PB Ratio is not ranked *
in the Business Services industry.
Industry Median: 1.6
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Thelma Therapeutics's adjusted book value per share data for the three months ended in Sep. 2022 was ₩429.061. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩3,496.56 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation


Thelma Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Thelma Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Cyclically Adjusted PB Ratio Chart

Thelma Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.57 0.61 1.48 1.66

Thelma Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.66 1.80 1.80 1.83

Competitive Comparison of Thelma Therapeutics's Cyclically Adjusted PB Ratio

For the Specialty Business Services subindustry, Thelma Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thelma Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Thelma Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Thelma Therapeutics's Cyclically Adjusted PB Ratio falls into.



Thelma Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Thelma Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6410.00/3496.56
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thelma Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, Thelma Therapeutics's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:

Adj_Book=Book Value per Share/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=429.061/114.8313*114.8313
=429.061

Current CPI (Sep. 2022) = 114.8313.

Thelma Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201212 9,440.767 97.168 11,156.919
201303 9,903.218 97.987 11,605.615
201306 9,308.404 97.732 10,937.013
201309 8,751.517 98.479 10,204.694
201312 7,946.462 98.279 9,284.817
201403 9,352.566 99.253 10,820.502
201406 7,044.823 99.353 8,142.343
201409 8,149.755 99.608 9,395.299
201412 4,558.475 99.098 5,282.202
201503 6,494.211 99.720 7,478.326
201506 7,038.662 100.050 8,078.548
201509 7,474.209 100.110 8,573.301
201512 2,051.633 100.220 2,350.745
201603 1,124.521 100.560 1,284.111
201606 1,468.104 100.790 1,672.629
201609 1,462.294 101.460 1,655.008
201612 1,678.413 101.560 1,897.739
201703 1,732.876 102.850 1,934.744
201706 2,720.711 102.610 3,044.760
201709 2,283.110 103.490 2,533.312
201712 1,703.180 102.990 1,899.004
201803 2,174.042 104.100 2,398.156
201806 1,722.325 104.130 1,899.326
201809 1,604.656 105.650 1,744.105
201812 653.671 104.350 719.328
201903 251.179 104.490 276.038
201906 174.698 104.880 191.274
201909 -437.596 105.200 -477.659
201912 281.743 105.120 307.771
202003 571.132 105.540 621.412
202006 496.244 104.870 543.381
202009 195.259 106.200 211.128
202012 59.673 105.765 64.788
202103 274.591 107.357 293.708
202106 -55.195 107.579 -58.916
202109 -132.076 108.759 -139.450
202112 573.494 109.676 600.449
202203 532.557 111.806 546.968
202206 457.008 114.083 460.006
202209 429.061 114.831 429.061

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Thelma Therapeutics  (XKRX:015540) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Thelma Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Thelma Therapeutics (XKRX:015540) Business Description

Traded in Other Exchanges
N/A
Address
Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines